B2M and malignant colon neoplasm: A similar trend towards improved outcome of patients with B2M-mutant tumours was observed when analysing tumour-related deaths, as no tumour-related deaths were observed in B2M-mutant colon cancer patients (data not shown); however, differences in OS were not statistically significant (log-rank test P=0.64).